Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metolazone vs. Furosemide Escalation in ADHF
NCT00904488Phase 4Terminated
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Oct 2008
- Primary completion
- May 2016
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metolazone in heart failure (HF), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Daily Net Fluid Output on Day 2 (24-48 Hours After Randomization). Started Oct 2008; status: terminated.
02
Drugs
metolazone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00904488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00904488.